TA-7284 Low

DRUG2 trials

Sponsors

Tanabe Pharma Corporation

Conditions

Type 2 Diabetes Mellitus

Phase 1

A Study to Evaluate the PK/PD and Safety of TA-7284 in Patients With Type 2 Diabetes Mellitus Who Have Moderate Renal Impairment

CompletedNCT01512849

Tanabe Pharma CorporationType 2 Diabetes Mellitus

Start: 2012-01-31End: 2012-09-30Updated: 2026-01-08

Phase 3

Efficacy and Safety Study of TA-7284 in Patients With Type 2 Diabetes

CompletedNCT01413204

Tanabe Pharma CorporationType 2 Diabetes Mellitus

Start: 2011-07-31End: 2012-08-31Updated: 2026-01-08